Your doctor wants to see what has changed
We will cover what the research actually says about GLP-1 receptor agonists and kidney function, which concurrent medications amplify the effect, and exactly what to do about it
To view a copy of this license, visit About this article Cite this article Begas, P., Liedgens, L., Moseler, A
In 2020 the first small-molecule structure (Zhao et al) revealed a druggable transmembrane sub-pocket distinct from the peptide-binding interface
Encourage them to bring questions to you or their doctor Position yourself as a partner: If you ever see something online and want to try it, lets look at it together. 6
1 2 3 4 Redondo, Roger L., and Richard G